Home

pľúca triviálne Ak môžeš ramirez 2012 temozolomide tropický iskra dynamika

Identification of a transient state during the acquisition of temozolomide  resistance in glioblastoma | Cell Death & Disease
Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma | Cell Death & Disease

Voltammetric/UV–Vis study of temozolomide inclusion complexes with  cyclodextrin derivatives - ScienceDirect
Voltammetric/UV–Vis study of temozolomide inclusion complexes with cyclodextrin derivatives - ScienceDirect

Up-regulation of miR-370-3p restores glioblastoma multiforme sensitivity to  temozolomide by influencing MGMT expression | Scientific Reports
Up-regulation of miR-370-3p restores glioblastoma multiforme sensitivity to temozolomide by influencing MGMT expression | Scientific Reports

PDF) Successful Pregnancy and Delivery after Concomitant Temozolomide and  Radiotherapy Treatment of Glioblastoma Multiforme
PDF) Successful Pregnancy and Delivery after Concomitant Temozolomide and Radiotherapy Treatment of Glioblastoma Multiforme

Cells | Free Full-Text | Intracellular Redox-Balance Involvement in  Temozolomide Resistance-Related Molecular Mechanisms in Glioblastoma | HTML
Cells | Free Full-Text | Intracellular Redox-Balance Involvement in Temozolomide Resistance-Related Molecular Mechanisms in Glioblastoma | HTML

Cells | Free Full-Text | Intracellular Redox-Balance Involvement in  Temozolomide Resistance-Related Molecular Mechanisms in Glioblastoma | HTML
Cells | Free Full-Text | Intracellular Redox-Balance Involvement in Temozolomide Resistance-Related Molecular Mechanisms in Glioblastoma | HTML

Genistein and Temozolomide-Loaded Polymeric Nanoparticles: A Synergistic  Approach For Improved Anti-Tumor Efficacy Against Glioblastoma -  ScienceDirect
Genistein and Temozolomide-Loaded Polymeric Nanoparticles: A Synergistic Approach For Improved Anti-Tumor Efficacy Against Glioblastoma - ScienceDirect

Elucidating the mechanisms of Temozolomide resistance in gliomas and the  strategies to overcome the resistance. - ScienceDirect
Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance. - ScienceDirect

Evaluation of Novel Imidazotetrazine Analogues Designed to Overcome  Temozolomide Resistance and Glioblastoma Regrowth | Molecular Cancer  Therapeutics
Evaluation of Novel Imidazotetrazine Analogues Designed to Overcome Temozolomide Resistance and Glioblastoma Regrowth | Molecular Cancer Therapeutics

Rindopepimut with temozolomide for patients with newly diagnosed,  EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind,  international phase 3 trial - The Lancet Oncology
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial - The Lancet Oncology

Evaluation of Novel Imidazotetrazine Analogues Designed to Overcome  Temozolomide Resistance and Glioblastoma Regrowth | Molecular Cancer  Therapeutics
Evaluation of Novel Imidazotetrazine Analogues Designed to Overcome Temozolomide Resistance and Glioblastoma Regrowth | Molecular Cancer Therapeutics

Cells | Free Full-Text | Intracellular Redox-Balance Involvement in  Temozolomide Resistance-Related Molecular Mechanisms in Glioblastoma | HTML
Cells | Free Full-Text | Intracellular Redox-Balance Involvement in Temozolomide Resistance-Related Molecular Mechanisms in Glioblastoma | HTML

Effect of long-term adjuvant temozolomide chemotherapy on primary  glioblastoma patient survival | BMC Neurology | Full Text
Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival | BMC Neurology | Full Text

Genistein and Temozolomide-Loaded Polymeric Nanoparticles: A Synergistic  Approach For Improved Anti-Tumor Efficacy Against Glioblastoma -  ScienceDirect
Genistein and Temozolomide-Loaded Polymeric Nanoparticles: A Synergistic Approach For Improved Anti-Tumor Efficacy Against Glioblastoma - ScienceDirect

Upregulation of CYP17A1 by Sp1-mediated DNA demethylation confers  temozolomide resistance through DHEA-mediated protection in glioma |  Oncogenesis
Upregulation of CYP17A1 by Sp1-mediated DNA demethylation confers temozolomide resistance through DHEA-mediated protection in glioma | Oncogenesis

An efficient and practical radiosynthesis of [11C]temozolomide. - Abstract  - Europe PMC
An efficient and practical radiosynthesis of [11C]temozolomide. - Abstract - Europe PMC

Genistein and Temozolomide-Loaded Polymeric Nanoparticles: A Synergistic  Approach For Improved Anti-Tumor Efficacy Against Glioblastoma -  ScienceDirect
Genistein and Temozolomide-Loaded Polymeric Nanoparticles: A Synergistic Approach For Improved Anti-Tumor Efficacy Against Glioblastoma - ScienceDirect

Biomedicines | Free Full-Text | Temozolomide and Other Alkylating Agents in  Glioblastoma Therapy | HTML
Biomedicines | Free Full-Text | Temozolomide and Other Alkylating Agents in Glioblastoma Therapy | HTML

Temozolomide nano enabled medicine: promises made by the nanocarriers in  glioblastoma therapy - ScienceDirect
Temozolomide nano enabled medicine: promises made by the nanocarriers in glioblastoma therapy - ScienceDirect

PDF) Effect of long-term adjuvant temozolomide chemotherapy on primary  glioblastoma patient survival
PDF) Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival

Identification of a transient state during the acquisition of temozolomide  resistance in glioblastoma | Cell Death & Disease
Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma | Cell Death & Disease

Efficacy of systemic temozolomide‐activated phage‐targeted gene therapy in  human glioblastoma | EMBO Molecular Medicine
Efficacy of systemic temozolomide‐activated phage‐targeted gene therapy in human glioblastoma | EMBO Molecular Medicine

Temozolomide-induced increase of tumorigenicity can be diminished by  targeting of mitochondria in in vitro models of patient individual  glioblastoma
Temozolomide-induced increase of tumorigenicity can be diminished by targeting of mitochondria in in vitro models of patient individual glioblastoma

Bortezomib administered prior to temozolomide depletes MGMT,  chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs  animal survival | British Journal of Cancer
Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival | British Journal of Cancer

Temozolomide nano enabled medicine: promises made by the nanocarriers in  glioblastoma therapy - ScienceDirect
Temozolomide nano enabled medicine: promises made by the nanocarriers in glioblastoma therapy - ScienceDirect

Transcriptional control of O6‐methylguanine DNA methyltransferase  expression and temozolomide resistance in glioblastoma - Happold - 2018 -  Journal of Neurochemistry - Wiley Online Library
Transcriptional control of O6‐methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma - Happold - 2018 - Journal of Neurochemistry - Wiley Online Library